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ABSTRACT
The use of virtual reality (VR) and mixed reality (MR) technology in 
clinical psychology is growing. Efficacious VR-based treatments for 
a variety of disorders have been developed. However, the field of 
technology-assisted psychotherapy is constantly changing with 
the advancement in technology. Factors such as interdisciplinary 
collaboration, consumer familiarity and adoption of VR products, 
and progress in clinical science all need to be taken into consid-
eration when integrating virtual technologies into psychothera-
pies. We aim to present an overview of current expert opinions on 
the use of virtual technologies in the treatment of anxiety and 
stress-related disorders. An anonymous survey was distributed to 
a select group of researchers and clinicians, using an analytic 
framework known as Strengths, Weaknesses, Opportunities, and 
Threats (SWOT). Overall, the respondents had an optimistic out-
look regarding the current use as well as future development and 
implementation of technology-assisted interventions. VR and MR 
psychotherapies offer distinct advantages that can overcome 
shortcomings associated with traditional therapy. The respon-
dents acknowledged and discussed current limitations of VR and 
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MR psychotherapies. They recommended consolidation of exist-
ing knowledge and encouraged standardisation in both theory 
and practice. Continued research is needed to leverage the 
strengths of VR and MR to develop better treatments.
Abbreviations: AR: Augmented Reality; MR: Mixed Reality; RCT: 
Randomised Controlled Trial; SWOT: Strengths, Weaknesses, 
Opportunities, and Threats; VR: Virtual Reality; VR-EBT: Virtual 
Reality Exposure-Based Therapy
Introduction
Nearly a decade ago, seventy mental health experts were asked to predict the trends in 
psychotherapy in the coming decade (Norcross et al., 2013). Out of the 45 interventions 
surveyed, “Use of virtual reality” was ranked the fourth most likely to increase in use. 
Virtual reality (VR) is defined as a computer-generated, three-dimensional synthetic 
environment that the user can immerse in and interact with (Riva, 2005). VR technol-
ogies offer exciting new possibilities for the treatment of psychological disorders, pri-
marily because of their ability to generate any environment or stimuli imaginable (Baus & 
Bouchard, 2014). Combining elements of the virtual world and the real world can create 
a mixed reality (MR). For instance, augmented reality (AR) is a subset of MR, where the 
background environment is physical, with certain virtual elements projected or merged 
into view (Baus & Bouchard, 2014; Milgram & Kishino, 1994). For the purpose of 
discussion in the current paper, the term VR refers to environments and stimuli that 
are entirely artificially constructed. The term AR refers specifically to the projection of 
virtual elements into real world environments. The term MR encompasses any degree of 
mixing of real and virtual elements, inclusive of AR and other forms of combination (e.g. 
presenting real world images inside a virtual environment).
One example of the successful integration of VR technology and psychotherapy is 
virtual reality exposure-based therapy (VR-EBT; also popularly known as VRET). VR- 
EBT has been used to treat a diverse range of specific phobias such as fear of spiders 
(Miloff et al., 2016), height (Emmelkamp et al., 2002; Rothbaum et al., 1995), driving 
(Wiederhold & Bouchard, 2014), and flying (Rothbaum et al., 2006; Wiederhold & 
Wiederhold, 2003). Other anxiety disorders successfully treated using VR-EBT include 
social anxiety disorder (Anderson et al., 2013), post-traumatic stress disorder (Botella 
et al., 2015; Cárdenas-López et al., 2013; McLay et al., 2011), and panic disorder (Botella 
et al., 2007). Meta-analyses have shown that VR-EBT is as effective as in vivo exposure- 
based therapy for the majority of these disorders (Carl et al., 2019; Kothgassner et al., 
2019; Opriş et al., 2012; Wechsler et al., 2019). Some common limitations associated with 
in vivo exposures can be addressed or minimised by the use of VR technology, notably 
the need for logistic planning (i.e. time and location), accessibility and controllability of 
the environment/stimuli, and anonymity/confidentiality of the patient (Maples-Keller 
et al., 2017; Neudeck & Einsle, 2012). In fact, both patients and clinicians have criticised 
in vivo exposure as ethically inappropriate (Deacon & Farrell, 2013; Olatunji et al., 2009), 
and surveys indicate that VR-EBT is more likely to be accepted by patients compared to 
traditional exposure (Garcia-Palacios et al., 2007). Besides exposure-based therapy, other 
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forms of VR psychotherapies have been used in areas such as adjustment disorder 
(Quero, Molés et al., 2019; Quero, Rachyla et al., 2019), eating disorders (Riva et al., 
2016), pain management (Kipping et al., 2012; Wiederhold, 2012), psychosis (Freeman 
et al., 2016), addictive disorders (Segawa et al., 2020), and neurological rehabilitation 
(Cuthbert et al., 2014).
Although not as commonly used as VR, mixed reality has its own advantages. For 
instance, augmented reality simultaneously preserves the realism of physical environments, 
and offers flexible presentation of virtual stimuli. This allows the patient to interact with the 
feared stimuli in realistic and natural settings, increasing the ecological validity of the 
therapeutic process (Baus & Bouchard, 2014). Studies suggest that AR-based exposure 
therapies can be as effective as VR-EBT or in vivo exposure (Suso-Ribera et al., 2019), and 
AR therapies have been successfully used to treat phobias in both single-case studies 
(Wrzesien et al., 2015) as well as randomised controlled trials (RCTs) (Botella et al., 2016).
The landscape of VR and MR is changing rapidly. The quality and realism of virtual 
environments are getting better with each generation of technology. The selection of 
consumer products is growing. Integration into devices such as personal computers and 
smartphones further increase the availability and accessibility of VR and MR in everyday 
life. All the while the cost of equipment is becoming more affordable. All these factors 
could benefit the development and implementation of VR and MR psychotherapies 
(Miloff et al., 2016). Nevertheless, it is important to acknowledge that limitations exist 
in both clinical research and practice, which may hinder the propagation and widespread 
use of technology-assisted psychotherapies (Mishkind et al., 2017; Page & Coxon, 2016).
This paper aims to explore the current state of VR and MR technology use in the 
treatment of anxiety and stress-related disorders. For this purpose, a survey was admi-
nistered to selected experts who work with VR and MR psychotherapies. Their opinions 
on what factors could promote or hinder the effective use, development, and implemen-
tation of technology-assisted psychotherapies are synthesised and discussed. We hope 
that this paper can update existing information regarding the use of VR and MR in 
clinical psychology, and provide recommendations for how to develop and implement 
such therapies in the future.
Method
A group of researchers were invited to share their thoughts on the current state of VR and 
MR technology use in the treatment of anxiety and stress-related disorders. The group 
was conveniently sampled due to their extensive knowledge and experience in the 
application of VR and MR psychotherapies (in clinics and/or research projects). 
Fourteen respondents were invited to participate, and all respondents accepted. The 
group consisted of eight women and six men, with four from the United States, three 
from Spain, two from Sweden, and one each from Canada, Germany, Italy, Mexico, and 
the Netherlands. This study did not involve any intervention, patient data or personal 
information, thus no independent ethical review was warranted.
To facilitate discussion in a practice-oriented manner, the survey was constructed 
following the analytical framework known as Strengths, Weaknesses, Opportunities, 
and Threats (SWOT). SWOT is an effective tool for situation analysis and strategic 
planning (Gürel, 2017), taking both internal (strengths and weaknesses) and external 
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(opportunities and threats) factors into consideration. SWOT evaluates favourable and 
unfavourable variables, and contextualises these variables in the development and 
implementation of projects. SWOT analysis helps to identify ways that strengths can 
be leveraged to create opportunities, and how weaknesses can be overcome to minimise 
threats (Helms & Nixon, 2010). This method is easy to use, and the practice-oriented 
nature makes it well-suited to highlight information relevant to the development and 
implementation of VR and MR psychotherapies. The SWOT framework has been 
successfully employed to evaluate other practices in clinical psychology (Rizzo & 
Kim, 2005; Rozental et al., 2014).
An online survey was sent to the respondents, using the guidelines in SWOT to facilitate 
discussion (see Appendix). The survey was anonymous in order to prevent social inhibition 
and risk of conformity. Once the survey was completed by all respondents, the answers 
were compiled and sent out again to all respondents so they could discuss and comment on 
each other’s views (anonymously). After the second round of comments, the responses 
were examined to identify recurring themes and summarized in a final draft, which was 
checked by the respondents before being submitted for potential publication. Respondents 
were free to add any information at any stage of this process, or make revisions in relation 




One of the core advantages of VR is the possibility to simulate any stimuli inside the 
virtual environment, even those that are difficult or impossible to access in real life. This 
means that VR and MR therapies can be adapted to treat a wide range of psychological 
disorders. Since virtual environments are not bound to physical locations, treatments can 
be delivered to populations residing in remote areas with little access to mental health 
care. As VR technology becomes more commonplace and affordable, VR and MR 
treatments can potentially be more economical compared to seeing a therapist face to 
face, especially for exposures to situations such as flying.
Control
Virtual reality technology allows for the precise control over everything that occurs inside the 
virtual environment, such as what stimuli the patient encounters, the exact properties of the 
stimuli (valence, intensity, frequency, and duration), and the conditions of stimuli onset/ 
removal (e.g. timing; behavioural triggers etc.). This makes it possible to tailor the treatment 
to meet the therapeutic needs of individual patients (Baños et al., 2009). Under these 
controlled conditions, the patient can progress through the treatment safely and gradually 
without being exposed to scenarios that they are not yet ready to tolerate. This gives the 
patient a sense of control, and can potentially increase their self-efficacy (Boeldt et al., 2019; 
Riva, 2005). Confidentiality is better protected as the treatment can take place in a private 
space. The increased sense of control, security, and confidentiality make virtual treatments 
more acceptable for some patients compared to in vivo exposure (Guillén et al., 2018; Quero 
et al., 2014). Furthermore, automated therapy procedures result in standardised treatments 
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that are consistent in quality and delivery, which cannot be guaranteed in traditional settings. 
In terms of scientific research, standardisation of therapy procedures facilitates systematic 
measurement and quantification of clinical outcomes, which makes it easier to identify 
mechanisms of change and maximise effective therapeutic elements (Botella et al., 2017). The 
methodological control is particularly useful in testing drug effects (Ressler et al., 2004).
Ecological validity
Several tools and strategies can be used in psychotherapy to work with stressed or 
anxious patients, from role playing job interviews to watching videos. However, these 
tools often fail to encapsulate the richness and complexity of real-life situations. VR 
provides contexts that can be more ecologically valid and representative of real-world 
settings and contexts. The immersive nature of VR and MR induces a stronger sense of 
presence than traditional media such as desktop computers. Presence refers to the feeling 
of “being there” inside the virtual world when the user is not physically there (Milgram & 
Kishino, 1994). High levels of presence have been found to positively associate with task 
performance, enjoyment, flow, and motivation (Lombard & Ditton, 1997; Price & 
Anderson, 2007; Sanchez-Vives & Slater, 2005; Witmer & Singer, 1998). The concept 
of presence is especially relevant to the application of VR in psychotherapy (Diemer et al., 
2015; Oh et al., 2018). Treatments such as exposure-based therapy often trigger anxiety to 
achieve therapeutic goals. A strong sense of presence ensures that the experiences and 
responses generated in the virtual environment are as similar to those from the real world 
as possible (Sanchez-Vives & Slater, 2005). AR technology can potentially achieve even 
higher ecological validity since the patient can interact with the virtual stimulus while 
remaining in the physical world (Baus & Bouchard, 2014).
Efficacy
Technology-assisted psychotherapies can be highly efficacious. VR-EBT is regarded as an 
effective treatment option for specific phobias and anxiety disorders in its own right. The 
high adaptability of virtual environments is well suited for exposure-based therapy. 
A growing body of literature has shown that VR-EBT is superior to wait-list control 
and exposure by imagination, and can be as effective as the “gold standard”—namely 
in vivo exposure (Carl et al., 2019; Emmelkamp et al., 2020; Wechsler et al., 2019). The 
legitimacy of VR based therapies is also reflected by the increasingly positive attitudes 
that clinicians have towards the use of VR technology in the treatment of anxiety 
disorders (Lindner, Miloff, Zetterlund et al., 2019). The development of other MR 
treatments is at a relatively early stage, thus warrants further investigation. Currently, 
the majority of studies comparing the efficacy of VR-EBT and in vivo therapies have 
applied exposure in the same way as in vivo therapy. However, exposure could be 
conducted in VR in ways that enhances effectiveness, such as by increasing the variety 
of exposure contexts, by augmenting exposure with fear antagonistic actions, or by 
maximising inhibitory learning.
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Weaknesses
Practical weaknesses
Although respondents were optimistic about the future of VR and MR therapies, 
there is a consensus that currently these treatments remain relatively inaccessible in 
general clinical practices. VR technologies are increasing in popularity, but are not 
yet an average household device. The investment needed to build basic infrastruc-
ture for treatment in the clinic can be prohibitively expensive, let alone scaling for 
mass dissemination. The rapid evolution of the VR technology landscape increases 
the risk of hardware quickly becoming obsolete. The scarcity of readily available, 
empirically validated treatment protocols or virtual environments means that VR 
programmes need to be designed from scratch, further increasing the development 
cost. Furthermore, there are relatively few standardised training courses available, so 
clinicians lack proper channels to learn about VR and MR psychotherapies even if 
they show interest. Many of these practical barriers can be overcome as consumer 
versions of VR technology become increasingly affordable and accessible (Donker 
et al., 2019; Lindner, Miloff, Hamilton et al., 2019; Wiederhold & Riva, 2019).
Clinical and theoretical weaknesses
The potentials of VR and MR therapies are well recognised, as evidenced by the fast 
proliferation of research on the topic in recent years. However, despite the promis-
ing results from many RCTs, the majority of these studies were conducted within an 
academic context. Different research groups have developed separate treatment 
protocols and virtual environments. This lack of standardisation makes it difficult 
to compare studies. It also complicates decision-making for clinicians who want to 
try out these treatments. Most of the research focus has been on symptom reduc-
tion, but research on the mechanisms of action remain relatively scarce. For 
instance, concepts such as sense of presence seem to play an important role in 
successful VR-EBTs (Lombard & Ditton, 1997; Price & Anderson, 2007), but it is 
not routinely measured in clinical studies. The commonly used term “exposure 
therapy” can also be misleading. It overemphasises a single (albeit important) 
component of a complex and dynamic therapeutic process. Studies have showed 
that the main predictors of treatment outcome in exposure-based therapies are the 
reduction in the strength of dysfunctional beliefs and the increase in self-efficacy 
(Côté & Bouchard, 2009; Tardif et al., 2019)
The interplay between technology and treatment also warrants careful examination. 
The use of a headset during therapy may create a barrier between the therapist and the 
patient, potentially affecting the development of therapeutic alliance (Meyerbröker & 
Emmelkamp, 2008), although this concern has been addressed in previous research (Ngai 
et al., 2015). The quality of the virtual environment, and the use of virtual avatars can 
affect sense of presence and immersion (Schwind et al., 2017), which in turn can 
influence therapeutic outcome. Automated treatments without direct therapist super-
vision might require the use of artificial intelligence to guide and interact with the patient 
during therapy sessions. If the algorithms are too rudimentary, the resultant simplistic 
interaction between the patient and the environment could reduce immersion and 
engagement. In order to overcome the clinical and theoretical shortcomings of virtual 
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psychotherapies, we need further research to better elucidate their mechanisms of action. 
Quality RCTs in clinical settings are needed to validate treatment effectiveness. 




VR and MR technologies are advancing at a rapid speed. Technological advancements 
increase the quality of the virtual environment and stimuli. Lower equipment cost and 
higher market penetration of commercial products can increase the accessibility and 
reach of virtual therapies. Development in multisensory integration means that VR is no 
longer restricted to visuospatial stimuli only. Integrated multisensory virtual environ-
ments can further enhance realism and immersiveness (Chau et al., 2017). Combining 
VR and other technologies can potentially improve the treatment experience. For 
instance, better artificial intelligence algorithms allow for the virtual environments to 
appropriately respond to participants’ behaviours (Dingli & Bondin, 2019). Integrating 
biosensors can provide physiological data, which can be correlated to behavioural and 
self-reported measures to provide a more comprehensive understanding of treatment 
effects (Kritikos et al., 2019). Biofeedback can also be utilised as a complementary 
psychophysiological intervention. Introducing gamification elements to virtual therapies 
could also promote treatment engagement and adherence (Nixon & Howard, 2013). In 
these cases, it is important that gamification is designed in a way to minimise the risks of 
fostering avoidance. In other words, it should serve as a motivator to increase task 
engagement, but not distract the patient from learning that feared stimuli are not 
threatening (Hoffman & Chu, 2019).
Clinical opportunities
The high adaptability of virtual treatments means that a centralised platform (e.g. 
a virtual clinic) can provide care for a range of different disorders concurrently. The 
highly flexible nature of virtual environments enables certain therapeutic strategies, such 
as introducing variable contexts and stimuli to maximise benefits from exposure (Baños 
et al., 2009; Shiban et al., 2015). Fully automated, technology-assisted treatments can be 
self-administered at home (Donker et al., 2019). The privacy and confidentiality that 
virtual treatments provide make them more acceptable to individuals who are reluctant 
to seek help from traditional therapy (Deacon & Farrell, 2013; Neudeck & Einsle, 2012). 
In light of the success of VR-EBT, researchers are branching out to explore how VR and 
MR can be applied to other forms of treatments. For instance, VR-based cognitive 
interventions have been considered to treat depression (Lindner, Hamilton et al., 
2019). Beyond treatment, VR technologies have also been incorporated into preventative 
or rehabilitative interventions. Examples include VR-based mindfulness training for 
spinal injury (Flores et al., 2018); social cognition training for autism (Manju et al., 
2018); stress inoculation training for first responders and other occupations at high risk 
of burnout (Gaggioli et al., 2014); and aggression prevention training for patients with 
psychiatric disorders (Klein Tuente et al., 2018).
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Threats
Quality assurance
The development of effective virtual therapies relies on the interdisciplinary integration of 
the theoretical knowledge from academia, the technological know-how from industries, 
and the appropriate implementation from clinicians (Boeldt et al., 2019). However, while 
academics and clinicians aim to develop the most effective treatments, companies often 
focus more on the business aspects of product development and consumption. Adding to 
this divergence of interest, there is also a stark contrast between the speed at which 
technologies are developing and the time it requires to conduct high-quality, evidence- 
based clinical research. Therefore, one major threat to VR and MR psychotherapies is 
quality assurance. For instance, currently there is little regulation and standardisation 
surrounding the development and dissemination of mobile applications that purportedly 
ameliorate symptoms of various disorders. The effectiveness of these applications is often 
not backed by empirical evidence (Portelli & Eldred, 2016). Not only do these products 
deliver little to no therapeutic effect, they can potentially be harmful when used inappro-
priately. The negative reputation generated by these pseudoscientific applications can 
hinder the implementation of legitimate, evidence-based virtual treatments.
Barriers to implementation
As stated above, the development of an effective treatment involves extensive research, an 
interdisciplinary development process that translates theory into practice, and an effec-
tive implementation strategy that maximises treatment efficacy. All of these crucial steps 
can drive up the costs associated with VR and MR psychotherapies, making them less 
competitive or economically infeasible. Putting aside the cost associated with research 
and development, implementing virtual treatment necessitates a minimum infrastructure 
investment (i.e. the hardware), which may prove to be a barrier depending on the 
affordability of the technology used. Furthermore, clinician-administered treatments 
would require therapist training and education to adopt VR technology into routine 
care. As a result, clinician attitude and competence regarding technology could impact 
the successful implementation of virtual treatments (Becker & Jensen-Doss, 2013; 
Lindner et al., 2020).
Side effects
The potential side effects associated with novel technologies can pose a threat to treat-
ments utilising VR or MR tools. There are ongoing debates regarding whether certain VR 
technologies can evoke side effects that make them unsuitable for certain populations. 
For instance, concerns about VR induced motion sickness (Kim et al., 2018) or photo-
sensitive seizures (Tychsen & Thio, 2020) warrant comprehensive research to assess the 
risks associated with VR-based therapies. Technological optimisation to improve the 
synchronisation of user movement and visuospatial cues from the VR environment can 
potentially reduce VR intolerance. Standardised safety and hygiene protocols (Bouchard 
et al., 2012) are needed to minimise the likelihood of exposing patients to negative side 
effects induced by VR technology, or health risks associated with sharing equipment.
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Discussion
The aim of this study was to explore the use of virtual technology in the treatment of 
anxiety and stress-related disorders. A group of experts in this field provided their 
opinions on the strengths and weaknesses associated with existing VR and MR psy-
chotherapies. Obstacles and challenges that might arise in the development and imple-
mentation of future virtual therapies were identified and discussed.
All experts included in this study agreed that VR and MR technologies have become 
a valuable tool for clinical psychology. Efficacious treatments for a variety of disorders 
have been demonstrated using virtual treatments such as VR-EBT. VR and MR therapies 
can overcome some fundamental limitations associated with in vivo exposure, notably 
the accessibility and controllability of the environment and stimuli, and the high expense 
associated with extended sessions. VR technologies can ensure a portable, controllable, 
and consistent therapeutic environment, be it in the clinic, hospital, or home setting 
(Lindner, Miloff, Fagernäs et al., 2019). Integration of VR and MR into common digital 
devices such as smartphones can result in widespread dissemination of virtual therapies 
(Fairburn & Patel, 2017), reaching those who lack access to traditional face-to-face 
interventions. Furthermore, the extensive control offered by virtual technologies can 
help implement and deliver the therapy using recommended techniques (Craske et al., 
2014) in a consistent manner, maximising the effect of treatment.
From a methodological perspective, the extensive control over the virtual environ-
ment or stimuli can be an important asset in elucidating therapeutic mechanisms. 
Researchers can systematically vary elements in the virtual environment to assess their 
impact on outcome (Shiban et al., 2013). Standardised delivery of stimuli also minimises 
noise from environmental confounds (Rothbaum, 2009). Unfortunately, the current 
reality is that standardisation is lacking, both in terms of VR development as well as in 
treatment protocols. This makes direct comparisons between studies difficult, since 
different labs may have used different VR hardware, software, or therapeutic procedures. 
Moreover, the majority of research on the efficacy of VR and MR therapies have been 
conducted in an academic context. As a result, the effectiveness of VR and MR psy-
chotherapies in natural settings is still unclear, which contributes to clinicians’ reluctance 
in adopting such novel treatments in their routine practice (Becker & Jensen-Doss, 2013). 
Luckily, some studies are introducing virtual therapies in primary care or at-home 
settings with promising results (Donker et al., 2019; Navarro-Haro et al., 2019).
The high cost of novel technology, especially high-end VR equipment, is often 
a barrier to the development and implementation of virtual therapies. However, as VR 
and MR technologies continue to mature and proliferate, simpler and more immersive 
systems are being offered at a much lower price (Valmaggia et al., 2016; Wiederhold & 
Riva, 2019). The affordability of virtual technologies is a double-edged sword, and 
presents itself as both an opportunity and a threat to virtual therapies. On the positive 
side, cheaper hardware promotes accessibility and usage, which means broader coverage 
of people who may benefit from virtual therapies. On the negative side, this also creates 
economic incentives to develop products that appeal to the masses, potentially leading to 
the dissemination of “treatments” that are not evidence-based nor effective 
(Chandrashekar, 2018; Portelli & Eldred, 2016).
COGNITIVE BEHAVIOUR THERAPY 517
In sum, the experts expressed their overall optimistic outlook regarding the future 
development and implementation of VR and MR psychotherapies. The unique strengths 
offered by VR and MR technologies can be leveraged to address limitations associated 
with traditional therapies. The advancement in technology is expected to eliminate some 
of the existing problems that virtual therapies face, but also create opportunities for 
better, more sophisticated treatments. Our experts acknowledged the weaknesses that VR 
and MR therapies currently suffer. They alluded to how these weaknesses could become 
potential threats, and cautioned against interventions that are not evidence-based. They 
recommended consolidation of existing knowledge surrounding VR and MR therapies, 
and encouraged standardisation both in theory and practice.
Several limitations need to be considered. Firstly, the number of experts included was 
relatively small, meaning that the results presented were limited in scope and some 
important aspects may not have been discussed. Secondly, although geographical aspects 
were considered at the time of respondent selection, all experts reside in Europe or North 
America. Therefore, cultural diversity in perspectives was missing in the results. It is not 
well understood whether behavioural responses to VR are uniform across cultures 
(Gorini et al., 2009; Qu et al., 2013). Differing cultural norms and socioeconomic realities 
can also impact opinions on the feasibility of VR and MR psychotherapies. Given the 
increasing number of RCTs carried out in regions such as Asia (Ali et al., 2019), a more 
geographically diverse sample of experts could provide valuable insights on these issues. 
Thirdly, all respondents have experience working with VR and MR psychotherapies. This 
convenient sample ensured extensive knowledge of the topic, but may have introduced 
biases in the results. We acknowledge the importance of addressing ethical concerns 
stemming from the use of novel technologies, especially in areas such as the long-term 
effects associated with VR usage, its effects on children’s development, and its regulation 
(Kenwright, 2018). Lastly, the responses were not coded or analysed using systematic 
qualitative methodology (e.g. thematic analysis). The analysis was summarising in 
nature, designed to combine and consolidate opinions from different respondents. 
Furthermore, there was overlap in the respondents’ answers to the positive categories 
(strengths and opportunities) and negative categories (weaknesses and threats), indicat-
ing unclear delineation between internal and external factors.
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Write your response to the following questions about what we are currently doing well with regard 
to using mixed realities in the treatment of anxiety and stress-related disorders, what could we 
improve upon, what opportunities exist that may help in future challenges, and what threats can be 
identified that might limit or prevent this particular line of intervention. You can be as brief or 
elaborate as you wish, and you are free to discuss research findings as well as your own theoretical 
opinions and clinical and methodological experiences.
1. Strengths: What are the advantages of using mixed realities in the clinical field? What are the 
advantages of using mixed realities in the treatment of anxiety disorders and stress-related 
disorders? How does the treatment of these disorders benefit from its use? What are we doing 
well in terms of using mixed realities in the treatment of anxiety disorders and stress-related 
disorders? How is it helpful for the patient and the therapist? What are the issues, events, or trends 
that positively impact the field right now (e.g. at a societal level, at an institutional level, or at 
a disciplinary level)?
2. Weaknesses: What are the current problems and what could we improve in the use of mixed 
realities for the treatment of anxiety and stress-related disorders? What are we doing poorly in 
terms of using mixed realities in the treatment of anxiety and stress-related disorders? What 
factors might be seen as limitations? Is there anything we are missing in our treatment, research, or 
implementation in this field? What are the issues, events, or trends that negatively impact the field 
right now (e.g. at a societal level, at an institutional level, or at a disciplinary level)?
3. Opportunities: What opportunities are currently available when using mixed realities within 
the anxiety and stress-related disorders field? What trends could we take advantage of? Are there 
any identified strengths that we could turn into opportunities? What is the main opportunity for 
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this field right now? And in the future? Opportunities can refer to needs that are not yet addressed 
or must be acted upon.
4. Threats: What threats could limit or become an obstacle to research, treatment, and/or 
implementation of using mixed realities to treat anxiety and stress-related disorders? Are there 
any identified weaknesses that might become threats? What is the main threat to this field right 
now? And in the future?
5. Additional question: Anything you would like to add and/or clarify?
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